Functional Dyspepsia Treatment Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Dyspepsia and Other Specified Disorders of Function of Stomach
Interventions
DRUG

Amitriptyline

25 mg capsule by mouth at bedtime for two weeks, then 50 mg capsule by mouth at bedtime for 10 weeks. The drug will be provided in blister packs.

DRUG

Escitalopram

10 mg tablets by mouth at bedtime for 12 weeks. The drug will be provided in blister packs.

DRUG

Placebo

Placebo escitalopram and placebo amitriptyline will be manufactured to ensure all tablets and capsules will be indistinguishable, and provided in blister packs.

Trial Locations (8)

32224

Mayo Clinic Jacksonville, Jacksonville

55905

Mayo Clinic, Rochester

60611

Northwestern University Chicago, Chicago

63130

Saint Louis University School of Medicine, St Louis

77030

Baylor College of Medicine, Houston

85259

Mayo Clinic, Scottsdale

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Unknown

McMaster University Centre, Hamilton

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER